Sense of Coherence and Empowerment at Patients With MUPS

Study Overview
=================
Brief Summary
-----------------
This is a study on Metacognitive therapy in general practice in Norway. The intervention is a small pilot study to examine whether Metacognitive therapy is feasible in an ordinary general practice. Will the physicians be capable to learn and provide the therapy method for their patients with MUPS and is is possible to implement this in an ordinary general practice routine? Both physicians and their patients will be asked to respond to a questionnaire on perceived utility of the treatment.

Detailed Description
-----------------
Metacognitive therapy is different from Cognitive therapy in the sense that it adresses the individual's attention towards potential worries and threats and also the management performed by the patient to avoid these. Also the individual's capacity to produce empowerment to manage these threats are of interest in the talks with the health care provider. - In this study, General Practitioners with specific training in Metacognitive therapy will be asked to recruit 2-3 patients with Medically Unexplained Physical Symptoms each and invite them to a series of Metacognitive Therapy. The patients and physicians will then provide their assessments of the treatment on a number of questionnaires. To explore the Sense of coherence and Empowerment among patients with Medically Unexplained Symptoms, the physicians will be asked to recruit six patients each to respond to a questionnaire.

Official Title
-----------------
Sense of Coherence and Empowerment at Patients With Medically Unexplained Physical Symptoms in General Practice

Conditions
-----------------
Medically Unexplained Symptoms, Sense of Coherence

Intervention / Treatment
-----------------
* Behavioral: Metacognitive Therapy


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: MUPS: Medically Unexplained Physical Symptoms somatic and mental examination sufficiently accomplished ongoing symptoms more than three months of disabeling symptoms Exclusion Criteria: not capable to respond on a written questionnaire in Norwegian

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Health Services Research
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Intervention<br>All patients recieve active treatment | Behavioral: Metacognitive Therapy<br>* Psychological treatment provided by the patient's regular general practitioner<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Feasibility in daily practice | The physicians will record the number of patients that agree to participate and complete the treatment | One year | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Effect of metacognitive therapy | Participating patients will respond on The Cognitive Attentional Syndrome Questionnaire (CAS-1) following each treatment session. A reduced score indicates improvement of symptom burden. | One year | 
| Effect of metacognitive therapy | Participating patients will respond on The Sense of Coherence Questionnaire (SOC-29) at start and at the end of the treatment. A reduced score indicates improvement of symptom burden. | One year | 
| Effect of metacognitive therapy | Participating patients will respond on The Short Form Health Survey RAND-36 at start and at the end of the treatment. A reduced score indicates improvement of symptom burden. | One year |